inDemic was a multidisciplinary team of scientists, physicians, and epidemiologists working to provide curated information and analysis on COVID-19 in the US and internationally. Our initial focus was to provide timely updates on the COVID-19 therapeutics landscape and vaccine pipeline.

We are no longer creating additional content, so our platform serves as an archive into how perspectives and timelines of COVID-19 vaccines and therapeutics played out from the beginning of the pandemic in Spring 2020 through early 2021 as vaccines rolled out across the U.S.

In “inDemic Perspectives”, we provide expert commentary on COVID-19 challenges and solutions. It is written with input from our scientific advisory board, which has decades of collective experience in critical care medicine, viral epidemiology, and microbiology. Our perspectives highlight broad issues spanning drug development, vaccine deployment, public health policy, and much more.

We have also recently begun conducting video interviews with our expert contributors. Check the inDemic Perspectives page or our Twitter @inDemicAlerts for these interviews to learn about the most pressing pandemic topics and to hear about the research that our contributors are conducting.